Litcius/Paper detail

HSP90: A promising target for NSCLC treatments

Yue Zhu, Zhaoxia Dai

2024European Journal of Pharmacology10 citationsDOI

Topics & Concepts

MedicineHsp90Hsp90 inhibitorDrugnon-small cell lung cancer (NSCLC)OncologyClinical trialHeat shock proteinPopulationToxicityLung cancerPharmacologyInternal medicineBiologyGeneA549 cellEnvironmental healthBiochemistryHeat shock proteins researchATP Synthase and ATPases ResearchEndoplasmic Reticulum Stress and Disease
HSP90: A promising target for NSCLC treatments | Litcius